Jinxian Huang

15PUBLICATIONS
14CO-AUTHORS
Rheumatology and arthritisMulticultural education (excl. Aboriginal and Torres Strait Islander, Māori and Pacific Peoples)Radiation therapyAutoimmunityTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 14, 2026
Real-world retention rate of secukinumab in patients with axial spondyloarthritis: Multi-centric retrospective data from China.

|Jan 20, 2026
Bridging Global Disparities in Drug Allergy Through AI-Assisted Training for Non-Specialists: Findings From the Multinational ADAPT-2 Course.

Hugo W F Mak, Juan Meng, Freya K L Chung

|Aug 02, 2024
Long-term follow-up of immunogenicity in radiographic axial spondyloarthritis patients: beyond drug survival and tapering. Comment on the article by Clarissa et al.

Jin-Xian Huang, Guo-Wen Zhang

|May 20, 2024
Case report: Inflammatory bowel disease triggered by secukinumab in a female case of axial spondyloarthritis accompanied with symptomatic epilepsy.

Lin Wen, Yan-Xia Chen, Jun-Ru Liu

|May 13, 2024
Comparable drug levels and immunogenicity in patients with axial spondyloarthritis treated with adalimumab originator and biosimilar: A retrospective study from two centers of China.

Zhong-Chao Fu, Xiao-Gui Cheng, Guo-Wen Zhang

|Dec 23, 2023
Personalized tapering of tumor necrosis factor inhibitor in axial spondyloarthritis.

Jin-Xian Huang, Yung-Heng Lee, Pui-Ying Leong

Pageof 3

Frequent Collaborators

5 joint publications

James Cheng-Chung Wei

3 joint publications

Lijun Zhang

2 joint publications

James Cheng-Chung Wei

1 joint publications

Yan Zhao